# Photronics Inc: Form 10-Q for the period ended Jan 28, 2018

- Company: [Photronics Inc](/companies/plab.md) (CIK 810136)
- Form: 10-Q
- Filed: 2018-03-09
- Accepted by EDGAR: Mar 8, 2018, 18:47 ET
- Period: 2018-01-28
- Accession: 0001140361-18-012686
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/810136/000114036118012686/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/810136/000114036118012686/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-01-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-10-30 to 2018-01-28 | $27.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-10-30 to 2018-01-28 | $4.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-10-30 to 2018-01-28 | $11.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-10-30 to 2018-01-28 | $11.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-10-30 to 2018-01-28 | −$1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-10-30 to 2018-01-28 | $5.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-10-30 to 2018-01-28 | $0.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-10-30 to 2018-01-28 | $0.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-10-30 to 2018-01-28 | 69,372,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2017-10-30 to 2018-01-28 | $30.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2017-10-30 to 2018-01-28 | $11.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-01-28 | $348.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-01-28 | $492.4m | us-gaap:AssetsCurrent |
| Total assets | at 2018-01-28 | $1.08bn | us-gaap:Assets |
| Current liabilities | at 2018-01-28 | $88.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-01-28 | $163.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-01-28 | $777.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 23,737 characters.

### Overview

Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for the fiscal 2017 year), that may cause actual results to materially differ from these expectations.

We sell substantially all of our photomasks to semiconductor and FPD designers and manufacturers. Photomask technology is also being applied to the fabrication of other higher performance electronic products such as photonics, micro-electronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and FPD designs and applications, particularly as they relate to the microeletronic industry's migration to more advanced product innovation, design methodologies and fabrication processes. We believe that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, FPD and photomask design and semiconductor and FPD production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity and accelerated erosion of selling prices.

We are typically required to fulfill customer orders within a short period of time, sometimes within 24 hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

In the first quarter of fiscal 2018, we announced the successful closing of the China joint venture agreement with Dai Nippon Printing Co., Ltd. (“DNP”), which we had agreed to enter into and announced in the third quarter of fiscal 2017. Under the agreement, our wholly-owned Singapore subsidiary owns 50.01% of the joint venture, which is named Photronics DNP Mask Corporation Xiamen (PDMCX), and a subsidiary of DNP owns the remaining 49.99%. The financial results of the joint venture are included in the Photronics, Inc. consolidated financial statements. See Note 5 of the condensed consolidated financial statements for additional information on the joint venture.

In the fourth quarter of fiscal 2017, we announced that Photronics UK, Ltd., our wholly owned subsidiary, signed an investment agreement with the Hefei State Hi-tech Industry Development Zone to establish a manufacturing facility in Hefei, China. Under the terms of the agreement, through our subsidiary, we will invest a minimum of $160 million, a portion of which may be funded with local borrowings, to build and operate a research and development and manufacturing facility for high-end and mainstream FPD photomasks. The Hefei State Hi-tech Industry Development Zone will provide certain investment incentives and support for this facility, which will have initial capability to produce up to G10.5+ large area masks and AMOLED products. Construction began in late 2017 and production is anticipated to commence in 2019.

In the fourth quarter of fiscal 2016, Photronics Singapore Pte, Ltd., a wholly owned subsidiary, signed an investment agreement with the Administrative Committee of Xiamen Torch Hi-Tech Industrial Development Zone (Xiamen Torch) to establish an IC manufacturing facility in Xiamen, China. Under the terms of the agreement, we will build and operate an IC facility to engage in research and development, manufacture and sale of photomasks, in return for which Xiamen Torch will provide certain investment incentives and support. This expansion is also substantially supported by customer commitments for its output. As discussed above, in the first quarter of fiscal 2018, we entered into a joint venture agreement with DNP, under which they obtained a 49.99% ownership interest in this facility. The total investment, per the agreement, is $160 million to be funded over the next several years with cash and local borrowings. Construction began in 2017 and production is anticipated to start in 2019.

### Material Changes in Results of Operations

### Three Months ended January 28, 2018, October 29, 2017 and January 29, 2017

The following table represents selected operating information expressed as a percentage of net sales.

|  | Three Months Ended January 28, 2018 | October 29, 2017 | January 29, 2017 |
| --- | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | (77.6) | (78.1) | (79.1) |
| Gross profit | 22.4 | 21.9 | 20.9 |
| Selling, general and administrative expenses | (9.5) | (8.4) | (9.9) |
| Research and development expenses | (3.3) | (3.2) | (3.1) |
| Operating income | 9.6 | 10.3 | 7.9 |
| Other income (expense), net | (3.4) | 0.4 | (1.9) |
| Income before income taxes | 6.2 | 10.7 | 6.0 |
| Income tax benefit (provision) | 1.5 | (2.0) | (1.9) |
| Net income | 7.7 | 8.7 | 4.1 |
| Net income attributable to noncontrolling interests | (2.9) | (4.2) | (2.3) |
| Net income attributable to Photronics, Inc. shareholders | 4.8% | 4.5% | 1.8% |

Note: All of the following tabular comparisons, unless otherwise indicated, are for the three months ended January 28, 2018 (Q1 FY18), October 29, 2017 (Q4 FY17) and January 29, 2017 (Q1 FY17) in millions of dollars.

### Revenue

| IC | Q1 FY18 FROM Q4 FY17 Revenue in Q1 FY18 | Percent Change | Increase (Decrease) | Q1 FY18 FROM Q1 FY17 Revenue in Q1 FY18 | Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| High-end | $33.4 | 9.6% | $2.9 | $33.4 | 50.6% | $11.2 |
| Mainstream | 62.3 | (5.0%) | (3.3) | 62.3 | (3.0%) | (1.9) |
| Total | $95.7 | (0.4%) | $(0.4) | $95.7 | 10.7% | $9.3 |
| FPD |  |  |  |  |  |  |
| High-end | $18.7 | 9.6% | $1.7 | $18.7 | 8.9% | $1.5 |
| Mainstream | 9.0 | 15.4% | 1.2 | 9.0 | 45.3% | 2.8 |
| Total | $27.7 | 11.4% | $2.9 | $27.7 | 18.5% | $4.3 |
| Total Revenue | $123.4 | 2.0% | $2.5 | $123.4 | 12.4% | $13.6 |

Revenue increased 2.0% in Q1 FY18, compared with Q4 FY17, mainly due to increased FPD and high-end IC revenues, partially offset by decreased mainstream IC sales. The high-end IC increase was driven by sales of high-end logic to Asian foundries. For FPD, demand for LCD masks improved as our customers released new designs in an effort to improve factory utilization. Sales of mainstream IC products were down due to seasonal softness.

Revenue increased 12.4% in Q1 FY18, compared with Q1 FY17, mainly due to increased FPD and high-end IC revenues, partially offset by decreased mainstream IC sales. The high-end IC increase was driven by high-end logic and memory sales to Asian foundries, as demand in the prior year had been soft for these products. For FPD, demand of LCD masks improved as our customers released new designs in an effort to improve factory utilization. Mainstream IC demand was softer compared to last year.

In Q1 FY18, we changed the threshold for the definition of high-end IC, from 45 nanometer or smaller to 28 nanometer or smaller, to reflect the overall advancement of technology in the semiconductor industry. All comparisons to prior period results in this MD&A reflect this modification. Our definition of high-end FPD products remains as G8 and above and active matrix organic light-emitting diode (AMOLED) display screens. High-end photomasks typically have higher ASPs than mainstream products.

The revenue momentum at the end of 2017 has continued into 2018. We anticipate that most of our high-end markets should continue to grow in Q2 FY18, the exception being high-end logic where, given the increase in business that we have experienced during the last two quarters, there may be a pause.

Our quarterly revenues can be affected by the seasonal purchasing tendencies of our customers. As a result, demand for our products is typically negatively impacted during the first, and sometimes the second, quarters of our fiscal year by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables present changes in revenue from Q4 FY17 and Q1 FY17 to Q1 FY18 by geographic area:

|  | Q1 FY18 FROM Q4 FY17 Revenue in Q1 FY18 | Percent Change | Increase (Decrease) | Q1 FY18 FROM Q1 FY17 Revenue in Q1 FY18 | Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Taiwan | $56.5 | 2.7% | $1.5 | $56.5 | 21.6% | $10.0 |
| Korea | 33.0 | 14.0% | 4.0 | 33.0 | 8.9% | 2.7 |
| United States | 25.0 | (5.5)% | (1.5) | 25.0 | 5.9% | 1.4 |
| Europe | 8.5 | (12.8)% | (1.2) | 8.5 | (2.8)% | (0.2) |
| Other | 0.4 | (48.7)% | (0.4) | 0.4 | (44.8)% | (0.3) |
|  | $123.4 | 2.0% | $2.4 | $123.4 | 12.4% | $13.6 |

### Gross Profit

|  | Three Months Ended Q1 FY18 | Q4 FY17 | Percent Change | Q1 FY17 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $27.7 | $26.4 | 4.6% | $23.0 | 20.3% |
| Gross margin | 22.4% | 21.9% |  | 20.9% |  |

Gross profit and gross margin both increased in Q1 FY18 from Q4 FY17 as a result of increased revenue and reduced labor and overhead costs, with the greatest reductions experienced in equipment maintenance and outsourced manufacturing costs. These reductions were somewhat offset by increased material costs. Gross profit and gross margin increased in Q1 FY18, compared with Q1 FY17, primarily due to an increase in overall revenue, which was predominantly driven by increased sales of high-end IC photomasks. We operate in a high fixed cost environment and, to the extent that our revenues and utilization increase or decrease, our gross margin and gross profit will generally be positively or negatively impacted.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $1.6 million, or 15.4%, to $11.8 million in Q1 FY18, from $10.2 million in Q4 FY17, primarily due to bad debt reserve adjustments that occurred in the prior quarter and increased professional fees in the current quarter. Selling, general and administrative expenses increased in Q1 FY18 by $0.9 million, or 8.1%, to $11.8 million, from $10.9 million in Q1 FY17, primarily as a result of increased professional fees, freight, and travel expenses, which increased as a result of activities related to our expansion into China.

### Research and Development

Research and development expenses primarily consist of development efforts related to high-end process technologies for 28nm and below IC nodes, G8 and above FPDs, and AMOLED applications. Research and development expenses increased by $0.3 million, or 6.9%, to $4.1 million in Q1 FY18 from $3.8 million in Q4 FY17, and by $0.6 million, or 17.8%, from Q1 FY17, with both of the increases primarily resulting from increased customer qualification costs for high-end IC reticles in the U.S.

### Other Income (Expense), net

|  | Three Months Ended Q1 FY18 | Q4 FY17 | Q1 FY17 |
| --- | ---: | ---: | ---: |
| Interest income and other income (expense), net | $(3.5) | $1.1 | $(1.5) |
| Interest expense | (0.6) | (0.6) | (0.6) |
| Other income (expense), net | $(4.1) | $0.5 | $(2.1) |

Other income (expense), net decreased in Q1 FY18 by $4.6 million and $2.0 million from Q4 FY17 and Q1 FY17, respectively. The decreases were primarily the result of significant foreign currency losses in Q1 FY18, while in Q4 FY17, we recognized a net gain, and in Q1 FY17, we recognized a more moderate loss from our cross-currency transactions.

### Income Tax Benefit (Provision)

|  | Three Months Ended Q1 FY18 | Q4 FY17 | Q1 FY17 |
| --- | ---: | ---: | ---: |
| Income tax benefit (provision) | $1.8 | $(2.5) | $(2.1) |
| Effective income tax rate | (23.1)% | 19.0% | 31.3% |

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances. The effective income tax rate decrease in Q1 FY18, compared with Q1 FY17 and Q4 FY17, is primarily attributable to the recognition of $3.9 million of previously unrecognized deferred tax benefits related to alternative minimum tax credits as a result of the U.S. Tax Cuts and Jobs Act ("Act"), which was signed into law on December 22, 2017 (See Note 8 to the condensed consolidated financial statements for further information), and an increase of deferred tax assets of $0.2 million, which was the result of an increase in the Taiwan tax rate. These benefits were partially offset by a higher percentage of income before income taxes being generated in jurisdictions where we recorded income tax provisions which, due to valuation allowances, were not offset by income tax benefits recorded in jurisdictions in which we incurred losses before income taxes.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $3.6 million in Q1 FY18, which represented a decrease of $1.5 million and an increase of $1.0 million from Q4 FY17 and Q1 FY17, respectively. The changes from both comparative periods were due to changes in net income at our IC manufacturing facility in Taiwan, in which we hold a 50.01% ownership interest.

### Liquidity and Capital Resources

Our working capital at the end of Q1 FY18 was $404.3 million, compared with $367.3 million at the end of Q4 FY17, and our cash and cash equivalents increased in Q1 FY18 by $40.5 million from $308.6 million at October 29, 2017. Favorable effects of foreign currency exchange rates contributed $9.7 million to our increase in cash in Q1 FY18. Net cash provided by operating activities was $30.9 million in Q1 FY18, compared with $31.5 million in Q1 FY17, as increased net income and noncash expenses were exceeded by net cash consumed by operating assets and liabilities by $0.7 million. Net cash used in investing activities was $11.1 million in Q1 FY18, a decrease of $4.3 million from the $15.4 million used in Q1 FY17. The decrease was primarily attributable to cash of $5.4 million used to acquire a business in Q1 FY17, which was somewhat offset by a $1.4 million increase in purchases of property, plant and equipment in Q1 FY18. Cash flows from financing activities increased from funds used of $0.2 million in Q1 FY17 to $11.2 million provided in Q1 FY18, primarily due to the receipt of $12.0 million from a noncontrolling interest for their investment in our recently established IC business in China.

As of January 28, 2018 and October 29, 2017, our total cash and cash equivalents included $213.3 million and $190.0 million, respectively, held by our foreign subsidiaries.

Our credit facility, which expires in December 2018, has a $50 million limit with an expansion capacity to $75 million, and is secured by substantially all of our assets located in the United States and the common stock of certain foreign subsidiaries. The credit facility is subject to a minimum interest coverage ratio, total leverage ratio and minimum unrestricted cash balance financial covenants, all of which we were in compliance with at January 28, 2018. We had no outstanding borrowings against the credit facility at January 28, 2018, and $50 million was available for borrowing. The interest rate on the credit facility (2.82% at January 28, 2018) is based on our total leverage ratio at LIBOR plus a spread, as defined in the credit facility.

As of January 28, 2018, we had capital commitments outstanding of approximately $190 million. We intend to finance our capital expenditures with our working capital, cash generated from operations, and, if necessary, additional borrowings. We have entered into a joint venture that is constructing an IC facility in China with an estimated total investment of $160 million. Our remaining funding commitment for the joint venture is approximately $68 million, over the next several years. We have also commenced construction of an FPD facility in China, in which we will invest $160 million over that same period. We believe that our cash on hand, cash generated from operations and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. We regularly review the availability and terms at which we might issue additional equity or debt securities in the public or private markets. However, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our capital requirements exceed our existing cash, cash generated by operations, and cash available under our credit facility.

Our liquidity, as we operate in a high fixed cost environment, is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). Depending on conditions in the semiconductor and FPD markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our credit facility.

### Off-Balance Sheet Arrangements

In January 2018, Photronics, through its wholly-owned Singapore subsidiary, and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Photronics DNP Mask Corporation Xiamen” ( “PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the Joint Venture Operating Agreement of Photronics DNP Mask Corporation Xiamen (“the Agreement”), DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX, that arise after the initial two year term of the Agreement, that cannot be resolved between the two parties. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of PDMCX's net assets, incur a loss.

In April 2014, we acquired a 50.01% controlling interest of PDMC, our IC manufacturing facility located in Taiwan. Under the PDMC joint venture operating agreement the shareholders of PDMC may be requested to make additional contributions to PDMC. In the event that PDMC requests additional capital from its shareholders, we may, in order to maintain a 50.01% ownership interest, be required to make such contributions to PDMC. The PDMC operating agreement limits the amount of contributions that may be requested during both PDMC’s first four years and during any individual year within those first four years. As of January 28, 2018, we had not been requested to make any additional capital contributions to PDMC.

We lease certain office facilities and equipment under operating leases that may require us to pay taxes, insurance and maintenance expenses related to the properties. Certain of these leases contain renewal or purchase options exercisable at the end of the lease terms.

### Business Outlook

A majority of our revenue growth is expected to continue to come from the Asian region, predominantly in China. In response to this expectation, we have entered into a joint venture that will complete the construction of an IC research and development and manufacturing facility in Xiamen, China, in late 2018. Production is anticipated to begin at this facility in 2019. In addition, in August 2017, we entered into an investment agreement to construct an FPD manufacturing facility in Hefei, China. Construction of this facility commenced in Q1 FY18, and production is anticipated to begin in 2019.

We continue to assess our global manufacturing strategy and monitor our revenue and related cash flows from operations. This ongoing assessment could result in future facility closures, asset redeployments, additional impairments of intangible or long-lived assets, workforce reductions, or the addition of increased manufacturing facilities, all of which would be based on market conditions and customer requirements.

Our future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties. While various risks and uncertainties were discussed in Part1, Item 1A in our Annual Report on Form 10-K for the year ended October 29, 2017, a number of other unforeseen factors could cause actual results to differ materially from our expectations.

### Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 13 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

## Market risk

As filed, 2,236 characters.

### Foreign Currency Exchange Rate Risk

We conduct business in several major international currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we have transactions and balances in Japanese yen.

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing manufacturing facility.

There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

As of January 28, 2018, a 10% adverse movement in the value of currencies different than the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $16.0 million, which represents an increase of $3.0 million from October 29, 2017. The increase in foreign currency rate change risk is primarily the result of increased US and JPY denominated exposures in Taiwan and South Korea.

### Interest Rate Risk

At January 28, 2018, we did not have any variable rate borrowings. A 10% change in interest rates would not have had a material effect on our consolidated financial position, results of operations, or cash flows in the three month period ended January 28, 2018.

## Controls and procedures

As filed, 1,942 characters.

### Evaluation of Disclosure Controls and Procedures

We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in its reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the first quarter of fiscal year 2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 155 characters.

There have been no material changes to risks relating to our business as disclosed in Part 1, Item 1A of our Form 10-K for the year ended October 29, 2017.

Filed Mar 9, 2018.
Source: SEC EDGAR, the filing index for accession 0001140361-18-012686. Last ingested by Listed: Nov 15, 2026, 01:00 ET. No prices; not investment advice.
